1-7 of 7
Oliver W. Press
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of a CD45-Targeted Antibody–Radionuclide Conjugate for High-Risk Lymphoma

Ryan D. Cassaday, Oliver W. Press, John M. Pagel, Joseph G. Rajendran, Ted A. Gooley, Darrell R. Fisher, Leona A. Holmberg, Robert S. Miyaoka, Brenda M. Sandmaier, Damian J. Green, Ajay K. Gopal
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 6932–6938.
https://doi.org/10.1158/1078-0432.CCR-19-1567
Published: 02 December 2019
View articletitled, Phase I Study of a CD45-Targeted Antibody–Radionuclide Conjugate for High-Risk Lymphoma
Open the PDF for Phase I Study of a CD45-Targeted Antibody–Radionuclide Conjugate for High-Risk Lymphoma in another window
Includes: Supplementary data
Journal Articles

A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab

Oliver W. Press, Joseph M. Unger, Lisa M. Rimsza, Jonathan W. Friedberg, Michael LeBlanc, Myron S. Czuczman, Mark Kaminski, Rita M. Braziel, Catherine Spier, Ajay K. Gopal, David G. Maloney, Bruce D. Cheson, Shaker R. Dakhil, Thomas P. Miller, Richard I. Fisher
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (23): 6624–6632.
https://doi.org/10.1158/1078-0432.CCR-13-1120
Published: 01 December 2013
View articletitled, A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab
Open the PDF for A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab in another window
Includes: Supplementary data
Journal Articles

Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

Steven I. Park, Jaideep Shenoi, Shani M. Frayo, Donald K. Hamlin, Yukang Lin, D. Scott Wilbur, Patrick S. Stayton, Nural Orgun, Mark Hylarides, Franz Buchegger, Aimee L. Kenoyer, Amanda Axtman, Ajay K. Gopal, Damian J. Green, John M. Pagel, Oliver W. Press
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7373–7382.
https://doi.org/10.1158/1078-0432.CCR-11-1204
Published: 30 November 2011
View articletitled, Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma
Open the PDF for Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

Pretargeted Radioimmunotherapy for B-Cell Lymphomas

Damian J. Green, John M. Pagel, Anastasia Pantelias, Nathan Hedin, Yukang Lin, D. Scott Wilbur, Ajay Gopal, Donald K. Hamlin, Oliver W. Press
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5598s–5603s.
https://doi.org/10.1158/1078-0432.CCR-07-1223
Published: 17 September 2007
View articletitled, Pretargeted Radioimmunotherapy for B-Cell Lymphomas
Open the PDF for Pretargeted Radioimmunotherapy for B-Cell Lymphomas in another window
Journal Articles

Induction of Apoptosis Using Inhibitors of Lysophosphatidic Acid Acyltransferase-β and Anti-CD20 Monoclonal Antibodies for Treatment of Human Non-Hodgkin's Lymphomas

John M. Pagel, Christian Laugen, Lynn Bonham, Robert C. Hackman, David M. Hockenbery, Rama Bhatt, David Hollenback, Heather Carew, Jack W. Singer, Oliver W. Press
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 4857–4866.
https://doi.org/10.1158/1078-0432.CCR-04-2352
Published: 06 July 2005
View articletitled, Induction of Apoptosis Using Inhibitors of Lysophosphatidic Acid Acyltransferase-β and Anti-CD20 Monoclonal Antibodies for Treatment of Human Non-Hodgkin's Lymphomas
Open the PDF for Induction of Apoptosis Using Inhibitors of Lysophosphatidic Acid Acyltransferase-β and Anti-CD20 Monoclonal Antibodies for Treatment of Human Non-Hodgkin's Lymphomas in another window
Journal Articles

Biodistribution of Yttrium-90–Labeled Anti-CD45 Antibody in a Nonhuman Primate Model

Eneida R. Nemecek, Donald K. Hamlin, Darrell R. Fisher, Kenneth A. Krohn, John M. Pagel, Frederick R. Appelbaum, Oliver W. Press, Dana C. Matthews
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 787–794.
https://doi.org/10.1158/1078-0432.787.11.2
Published: 08 February 2005
View articletitled, Biodistribution of Yttrium-90–Labeled Anti-CD45 Antibody in a Nonhuman Primate Model
Open the PDF for Biodistribution of Yttrium-90–Labeled Anti-CD45 Antibody in a Nonhuman Primate Model in another window
Journal Articles

Synergistic Effects of the Fenretinide (4-HPR) and Anti-CD20 Monoclonal Antibodies on Apoptosis Induction of Malignant Human B Cells

Daming Shan, Ajay K. Gopal, Oliver W. Press
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2490–2495.
Published: 01 August 2001
View articletitled, Synergistic Effects of the Fenretinide (4-HPR) and Anti-CD20 Monoclonal Antibodies on Apoptosis Induction of Malignant Human B Cells
Open the PDF for Synergistic Effects of the Fenretinide (4-HPR) and Anti-CD20 Monoclonal Antibodies on Apoptosis Induction of Malignant Human B Cells in another window